Zurich, Switzerland: +41 - 43 434 80 33   |   US: (510) 962-8903   |   support@traininng.com

Kelly Thomas

Vice President, Americas Quality Operations at Stallergenes

Kelly Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.



  •  Thursday, April 4, 2019
  • 10:00 AM PDT | 01:00 PM EDT,
  • 90 Minutes
  • ¤150.00
Aseptic Processing Overview and Validation

This course will provide an overview of the requirements for aseptic and bulk manufacturing operations, including facility design, contamination controls and acceptable personnel behaviors.

  •  Monday, April 8, 2019
  • 10:00 AM PDT | 01:00 PM EDT,
  • 90 Minutes
  • ¤150.00
How to Write Effective 483 and Warning Letter Responses

This 90-minute course will discuss the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters.





  • Recorded
  • View Anytime
  • 90 Minutes
  • ¤190.00
Aseptic Processing Overview and Validation

This course will provide an overview of the requirements for aseptic and bulk manufacturing operations, including facility design, contamination controls and acceptable personnel behaviors.

  • Recorded
  • View Anytime
  • 90 Minutes
  • ¤190.00
How to Write Effective 483 and Warning Letter Responses

This 90-minute course will discuss the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters.